A Clinical Study Exploring CT1190B in the Treatment of Patients With Relapsed/Refractory B-cell Non-Hodgkin Lymphoma ( CT1190B-CG1101 )
Clinical trial NCT07032324 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07032324
- Sponsor
- Qian Wenbin
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-08
- Primary completion
- 2025-12-30
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.